"St. Luke's Hospital - Allentown Campus features advanced inpatient and outpatient services with full access to the latest treatments and technologies. Patients benefit from quality inpatient care, emergency room services, surgical services, radiology services and more."

During the past decade, St. Luke's Hospital - Allentown Campus conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Hospital - Allentown Campus" #1 sponsor was "Pfizer" with 4 trials, followed by "ASTORA Women's Health" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Impulse Dynamics" with 1 trials sponsored and "Janssen Scientific Affairs, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Hospital - Allentown Campus" #1 collaborator was "Ain Shams University" with 1 trials as a collaborator, "Burke Rehabilitation Hospital" with 1 trials as a collaborator, "Burwood Hospital, Christchurch, New Zealand" with 1 trials as a collaborator, "Chonnam National University Hospital" with 1 trials as a collaborator and "Fairlawn Hospital, Worcester, MA, USA" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Hospital - Allentown Campus" are "Fecal Incontinence" (2 trials), "Advanced Breast Cancer" (1 trials), "Atrial Fibrillation" (1 trials), "Contraception" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "St. Luke's Hospital - Allentown Campus" in a lesser frequency.

Most popular intervention types in "St. Luke's Hospital - Allentown Campus" are "Device" (4 trials), "Drug" (3 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Augmented activity feedback" (1 trials), "Avelumab (MSB0010718C)" (1 trials), "Axitinib (AG-013736)" (1 trials), "Blood draw" (1 trials) and "Dacarbazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Hospital - Allentown Campus" are 7 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "St. Luke's Hospital - Allentown Campus". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in St. Luke's Hospital - Allentown Campus, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Hospital - Allentown Campus, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".